# Resilience and residuals beyond containment — The hidden burden of Bundibugyo Ebola virus survivorship sixteen years on: A cross-sectional observational study

**Authors:** Raymond Ernest Kaweesa, Joseph Ssebwana Katende, Raymond Reuel Wayesu, Annie Daphine Ntabadde, Solomon Opio, Laban Kato, Gerald Kevin Oluka, Ruth Nambi, Rodney Abraham Tumusiime, Pontiano Kaleebu, Julius Julian Lutwama, Jennifer Serwanga

PMC · DOI: 10.1016/j.nmni.2025.101685 · New Microbes and New Infections · 2025-12-13

## TL;DR

This study finds that survivors of Bundibugyo Ebola virus experience long-term health and psychosocial effects, even 16 years after infection.

## Contribution

The study provides the first long-term data on health outcomes of Bundibugyo Ebola virus survivors.

## Key findings

- Survivors showed persistent neurological and musculoskeletal symptoms like headaches and visual disturbances.
- Elevated basophils and urinary ketones suggest chronic inflammation and metabolic shifts.
- Despite normal vital signs, 57.5% of survivors reported ongoing stigma.

## Abstract

Long-term effects of Ebola disease (EBOD) are well documented for Ebolavirus (EBOV), but limited data exist for Bundibugyo virus disease (BVD) caused by Bundibugyo Ebola virus (BDBV), a genetically distinct strain.

We conducted a cross-sectional observational study involving 40 laboratory-confirmed BVD survivors and 23 age- and sex-matched unexposed community controls to evaluate the long-term clinical, biochemical, immunological, and psychosocial sequelae associated with BDBV infection. Participants underwent comprehensive clinical evaluations, laboratory testing, and standardised mental health assessments. Statistical comparisons used rank-sum, chi-squared, and correlation analyses.

Survivors exhibited persistent multisystem symptoms, with neurological and musculoskeletal complaints most frequent, headaches (35 %) and visual disturbances (22.5 %). Laboratory findings showed elevated basophils (40 %) and urinary ketones (5 %), indicating possible chronic inflammation and metabolic shifts. Respiratory rates were significantly reduced in survivors (p < 0.001), while other vital signs and biochemical markers were largely within normal ranges. Despite high resilience, 70 % with normal anxiety scores and 62.5 % with normal depression scores, 57.5 % reported persistent stigma. Survivors also exhibited unique physiological correlations, suggestive of post-infectious homeostatic changes.

BVD survivors experience long-term multisystem sequelae and physiological remodeling. These findings support the need for virus-specific post-BVD care and sustained follow-up to inform survivor health policy.

•Sixteen years post-infection, Bundibugyo Ebola virus survivors show persistent respiratory and psychosocial symptoms.•Cardiometabolic and thermoregulatory parameters remain largely within normal ranges.•Subtle biochemical changes suggest low-grade inflammation and metabolic stress.•Findings highlight the need for long-term clinical follow-up of filovirus survivors.

Sixteen years post-infection, Bundibugyo Ebola virus survivors show persistent respiratory and psychosocial symptoms.

Cardiometabolic and thermoregulatory parameters remain largely within normal ranges.

Subtle biochemical changes suggest low-grade inflammation and metabolic stress.

Findings highlight the need for long-term clinical follow-up of filovirus survivors.

## Full-text entities

- **Diseases:** Long-term effects of Ebola disease (MESH:D000069451), depression (MESH:D003866), headaches (MESH:D006261), musculoskeletal (MESH:D009140), BVD (MESH:D014777), visual disturbances (MESH:D014786), chronic (MESH:D002908), EBOD (MESH:D019142), inflammation (MESH:D007249), anxiety (MESH:D001007)
- **Chemicals:** ketones (MESH:D007659)
- **Species:** EBOV [taxon 186536], Bundibugyo virus (no rank) [taxon 565995]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13033831/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13033831/full.md

## References

43 references — full list in the complete paper: https://tomesphere.com/paper/PMC13033831/full.md

---
Source: https://tomesphere.com/paper/PMC13033831